AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 203 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $324,225 | -52.4% | 13,100 | -45.6% | 0.00% | -50.0% |
| Q3 2022 | $681,000 | -41.2% | 24,078 | -39.5% | 0.00% | -50.0% |
| Q1 2022 | $1,159,000 | +105.5% | 39,822 | +132.1% | 0.00% | +100.0% |
| Q4 2021 | $564,000 | -13.4% | 17,155 | +21.7% | 0.00% | 0.0% |
| Q3 2021 | $651,000 | +133.3% | 14,100 | +119.1% | 0.00% | +100.0% |
| Q4 2020 | $279,000 | -90.8% | 6,435 | -88.6% | 0.00% | -94.7% |
| Q2 2020 | $3,027,000 | -32.2% | 56,600 | -55.0% | 0.02% | -44.1% |
| Q1 2020 | $4,466,000 | -24.5% | 125,895 | +1.6% | 0.03% | -15.0% |
| Q4 2019 | $5,916,000 | +237.3% | 123,900 | +128.8% | 0.04% | +166.7% |
| Q3 2019 | $1,754,000 | -26.1% | 54,147 | +13.8% | 0.02% | -28.6% |
| Q2 2019 | $2,374,000 | +0.6% | 47,600 | +36.1% | 0.02% | +16.7% |
| Q1 2019 | $2,359,000 | -23.8% | 34,972 | -47.9% | 0.02% | -21.7% |
| Q4 2018 | $3,094,000 | +57.9% | 67,102 | +164.1% | 0.02% | +130.0% |
| Q3 2018 | $1,959,000 | +190.7% | 25,403 | +217.5% | 0.01% | +150.0% |
| Q2 2018 | $674,000 | +13380.0% | 8,000 | +7900.0% | 0.00% | – |
| Q2 2017 | $5,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |